We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current AMRN market cap is 180.91M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.06M | 74.71M | 55.16M | 68.85M | 42.3M |
| Operating Income | -22.03M | -160.83M | -13.58M | -524k | -23.21M |
| Net Income | -19.31M | -5.78M | -9.95M | 1.52M | -25.13M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 429.76M | 614.06M | 583.19M | 369.19M | 306.91M |
| Operating Income | -24.35M | -19.66M | 10.5M | -105.87M | -67.59M |
| Net Income | -22.65M | -18M | 7.73M | -105.8M | -59.11M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 839.03M | 831.68M | 790.01M | 799.86M | 750.62M |
| Total Liabilities | 285.88M | 279.59M | 244.08M | 247.98M | 219.24M |
| Total Equity | 553.15M | 552.1M | 545.94M | 551.88M | 531.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 882.21M | 966.02M | 1.07B | 886.18M | 831.68M |
| Total Liabilities | 273.95M | 338.52M | 400.97M | 290.85M | 279.59M |
| Total Equity | 608.26M | 627.51M | 667.1M | 595.33M | 552.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.53M | 6.88M | -12.6M | -15.35M | -17.71M |
| Investing | 45.48M | -25.52M | 28.72M | 33.41M | -23.14M |
| Financing | 147k | 230k | -1.43M | -1.39M | -1.46M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.37M | -21.75M | -66.54M | -180.09M | 6.88M |
| Investing | -2.48M | -376.96M | 104.1M | 175.29M | -25.52M |
| Financing | 409.61M | -58.91M | -5.07M | -379k | 230k |
| Market Cap | 180.91M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 411.34M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0.36%) |
| Company Name | Amarin Corp PLC |
| Address |
one new change london EC4M 9AF |
| Website | https://www.amarincorp.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
